Data as of 3:59pm ET
| +0.86 / +16.81%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 19.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +219.87% increase from the last price of 5.94.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.